Patents/Assignees

Alpine Immune Sciences, Inc.

15 patents in portfolio

US12612447utility2026
April and BAFF Inhibitory Immunomodulatory Proteins and Methods of Use Thereof
0 cites
US12612446utility2026
CTLA-4 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US12552853utility2026
CD86 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US12486312utility2025
Immunomodulatory Proteins with Tunable Affinities
0 cites
US12358969utility2025
CTLA-4 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US12304943utility2025
April and BAFF Inhibitory Immunomodulatory Proteins and Methods of Use Thereof
0 cites
US12297253utility2025
Multi-domain Immunomodulatory Proteins and Methods of Use Thereof
0 cites
US12202882utility2025
APRIL and BAFF Inhibitory Immunomodulatory Proteins and Methods of Use Thereof
0 cites
US12110339utility2024
ICOS Ligand Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US12065476utility2024
PD-1 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US11834490utility2023
CD112 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US11753458utility2023
CTLA-4 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US11732022utility2023
PD-L2 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US11639375utility2023
CD80 Variant Immunomodulatory Proteins and Uses Thereof
0 cites
US11613566utility2023
Variant ICOS Ligand Immunomodulatory Proteins and Related Compositions and Methods
0 cites